CTI BioPharma
CTIC
#5622
Rank
S$1.55 B
Marketcap
S$11.78
Share price
0.00%
Change (1 day)
26.68%
Change (1 year)

CTI BioPharma (CTIC) - Total liabilities

Total liabilities on the balance sheet as of March 2023 : S$0.17 Billion

According to CTI BioPharma 's latest financial reports the company's total liabilities are S$0.17 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

CTI BioPharma - Total liabilities on balance sheet (from 2001 to 2023)

Total liabilities by year

Year Total liabilities Change
2022-12-31S$0.19 B107.23%
2021-12-31S$92.83 M285.3%
2020-12-31S$24.09 M-36.96%
2019-12-31S$38.22 M-24.17%
2018-12-31S$50.4 M-2.87%
2017-12-31S$51.88 M-36.08%
2016-12-31S$81.17 M-40.79%
2015-12-31S$0.13 B92.82%
2014-12-31S$71.09 M10.11%
2013-12-31S$64.57 M29.52%
2012-12-31S$49.85 M12.47%
2011-12-31S$44.32 M-41.41%
2010-12-31S$75.66 M-39.01%
2009-12-31S$0.12 B-53.83%
2008-12-31S$0.26 B2.94%
2007-12-31S$0.26 B-16.32%
2006-12-31S$0.31 B-28.64%
2005-12-31S$0.43 B4.79%
2004-12-31S$0.41 B7.39%
2003-12-31S$0.38 B56.23%
2002-12-31S$0.24 B-30.83%
2001-12-31S$0.35 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Amgen
AMGN
S$104.39 B 58,410.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$101.49 B 56,788.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
S$2.17 B 1,120.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
S$17.95 B 9,966.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$118.08 B 66,086.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$42.26 B 23,590.04%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
S$81.07 B 45,342.13%๐Ÿ‡จ๐Ÿ‡ญ Switzerland